'China's VR industry is expected to be worth 54.45 billion yuan ($8 billion) next year, with an annual growth rate of about 95.2 percent, according to a report from the China Center for Information Industry Development, a research institute affiliated with the ministry.'
Yep given that AGL are in their strongest ever position i would be amazed if this level did not hold. Close to raise price plus recent director buys. Great buying opp for gradual rerate over next few months.
For the patient i think it should be fairly easy money from here.
I thought it was a great update, there's loads going on at the moment.
Unoptimised in vivo study using Covid plus other plasmids to commence imminently - Tick Optimised to follow in early 2021 - Tick Currently testing Nuvec under different storage conditions - Tick Optimisation work / Dispersion work complete (now greater potential of working using less injections) - Tick Oral feasibility started well as the co has 'now demonstrated that Nuvec® protects plasmid DNA from both acid and nuclease digestion'. Final results before EOY - Tick
I think people have missed that the unoptimised Nuvec in vivo study is starting now. It's the optimised version that will be starting at a slightly later date.
The co has caught my attention again recently as it at near lows. Read the rns with a bit of interest this morning but having just seen a video of the sanitisaton tunnel (on WSG Twitter feed) it looks like i could knock up something just as effective in my back garden with a tent and a few hand pump sprays....
Lol nether the less at the 5-6p level it's probably a buy.